European Medical Contract Manufacturing
EMCM is a full service contract manufacturer dedicated to supporting innovations and breakthroughs in the healthcare sector, producing a broad range of medical products including pharmaceuticals and medical devices. Established in 1993, EMCM operates GMP and ISO accredited facilities, focusing on niche markets with unique product qualities, and aims to positively impact lives worldwide through high-quality products and services. The company emphasizes quality, innovation, and customer support, offering end-to-end solutions from product development to distribution.
Industries
Nr. of Employees
medium (51-250)
European Medical Contract Manufacturing
Products
Bone cement formulations for arthroplasty and vertebroplasty
Powder-based bone cements manufactured and supplied for hip/knee arthroplasty and vertebroplasty surgical procedures.
Resorbable collagen membranes for dental/periodontal use
Acellular, resorbable collagenous membranes processed from animal pericardium (decellularised and delipidised) intended as a biodegradable barrier for guided bone and tissue regeneration.
Gelatin-based cement restrictor and anti-adhesive gels
Medical device-grade gelatin-based cement restrictors and anti-adhesive gel formulations for use in joint replacement and spinal procedures.
Bone cement formulations for arthroplasty and vertebroplasty
Powder-based bone cements manufactured and supplied for hip/knee arthroplasty and vertebroplasty surgical procedures.
Resorbable collagen membranes for dental/periodontal use
Acellular, resorbable collagenous membranes processed from animal pericardium (decellularised and delipidised) intended as a biodegradable barrier for guided bone and tissue regeneration.
Gelatin-based cement restrictor and anti-adhesive gels
Medical device-grade gelatin-based cement restrictors and anti-adhesive gel formulations for use in joint replacement and spinal procedures.
Services
End-to-end production including formulation, aseptic or terminal sterilisation, fill-and-finish into multiple primary containers and scale-up from pilot to GMP batches.
Laboratory-to-production transfers, process design, validation studies (cleaning, mixing, sterilisation, CCI), and generation of validation documentation for regulatory submissions.
In-house steam sterilisation and management of alternative sterilisation routes (radiation, ethylene oxide) and supercritical CO2 approaches for temperature-sensitive materials.
Qualified lyophilisation capacity for production-scale batches with automated vial stoppering and adaptable cycle development.
In-house blistering, pouching, labelling (including UDI) and final packaging with validated secondary packaging workflows.
GMP-compliant storage with temperature control (15–25°C, 2–8°C, -20°C, -80°C), ERP inventory management, FEFO handling and global distribution support.
End-to-end production including formulation, aseptic or terminal sterilisation, fill-and-finish into multiple primary containers and scale-up from pilot to GMP batches.
Laboratory-to-production transfers, process design, validation studies (cleaning, mixing, sterilisation, CCI), and generation of validation documentation for regulatory submissions.
In-house steam sterilisation and management of alternative sterilisation routes (radiation, ethylene oxide) and supercritical CO2 approaches for temperature-sensitive materials.
Qualified lyophilisation capacity for production-scale batches with automated vial stoppering and adaptable cycle development.
In-house blistering, pouching, labelling (including UDI) and final packaging with validated secondary packaging workflows.
GMP-compliant storage with temperature control (15–25°C, 2–8°C, -20°C, -80°C), ERP inventory management, FEFO handling and global distribution support.
Expertise Areas
- Contract manufacturing of sterile medicinal products
- Aseptic fill-and-finish
- Lyophilisation process services
- Tissue-derived biomaterials processing
Key Technologies
- Aseptic filling (RABS and closed systems)
- Lyophilisation (freeze-drying)
- Steam sterilisation
- Gamma/x-ray/beta/EO sterilisation management
News & Updates
EMCM participated in CPHI Milan, welcoming many relations and new customers, discussing potential collaborations and support opportunities.
EMCM's participation in CPhI Barcelona 2023 was a great success, with many visitors and interesting requests, supporting opportunities and bringing innovations to the market.
EMCM participated in CPHI Milan, welcoming many relations and new customers, discussing potential collaborations and support opportunities.
EMCM's participation in CPhI Barcelona 2023 was a great success, with many visitors and interesting requests, supporting opportunities and bringing innovations to the market.